Reports submitted in 2024-Q1 · page 5
Backfill quarter. Reports assayed earlier were accepted retrospectively where custody could be documented. Median purity for the quarter is 99.09 % area, n=163. Read the 2024-Q1 state-of-the-index report →
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2024-005305 | Semaglutide | GL Biochem | GLBI-2401-F8702 | Nordanalyt | 2024-Q1 | 99.06 | 3.01 | 99.6 | Supplier-supplied | 1 | MARGINAL |
| AX-2024-004360 | TB-500 | QSC | QSC-2401-S7715 | Janoshik | 2024-Q1 | 99.46 | 6.38 | — | Laboratory-retained | 2 | MARGINAL |
| AX-2024-004430 | Tirzepatide | QSC | QSC-2402-D9020 | PeptideMeter | 2024-Q1 | 98.91 | 4.37 | — | Supplier-supplied | 1 | MARGINAL |